Hematologic Malignancy

Plasma Cell Neoplasm

HematologicNon-malignant831 active trials25 approved drugs26 evidence items

NCIt: C4665
MeSH: D054219

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (117)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 117 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Pre-CAR-HEMATOTOX at Leukapheresis Predicts Delayed Platelet Recovery After Idecabtagene Vicleucel in Multiple Myeloma.
Taku Kikuchi, Moe Nomura-Yogo, Ukyo Kondo et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42542408 · candidate dictionary pubmed
Belantamab Mafodotin for Patients With Multiple Myeloma: Clinical Development and Practical Strategies for Dose Optimization and Toxicity Management.
Roberto Mina, Evangelos Terpos, Lorenzo Cani et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42521571 · candidate dictionary pubmed
Dual bispecific protein engager-armed T cells targeting BCMA and B7-H3 overcome antigen heterogeneity in multiple myeloma.
Thanida Chanpong, Nunghathai Sawasdee, Kamonlapat Supimon et al. · Biomed Pharmacother · Sep 1, 2026 · PMID 42497585 · candidate dictionary pubmed
Knowledge, Awareness, and Practice Patterns of Nephrologists in the Diagnosis and Management of Multiple Myeloma (MIND-MM Study): A Cross-Sectional, Web-Based, CHERRIES-Compliant Survey with Position Statement from the Indian Myeloma Academic Groupe (IMAGe) and Indian Society of Nephrology (ISN).
Uday Yanamandra, Raja Ramachandran, Vinay Sakhuja et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42471300 · candidate dictionary pubmed
Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma.
Fen He, Junjun Li, Lijun Peng et al. · Int J Oncol · Sep 1, 2026 · PMID 42464653 · candidate dictionary pubmed
Kidney Transplantation Post-Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma.
Zahraa Khan, Darshana M Dadhania, Eugene Brailovski et al. · Am J Kidney Dis · Sep 1, 2026 · PMID 42379467

· candidate dictionary

pubmed

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo et al. · Am J Hematol · Sep 1, 2026 · PMID 42351384 · candidate dictionary pubmed

NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.

Liuting Chen, Feifei Cheng, Yung-Hsing Huang et al. · Drug Resist Updat · Sep 1, 2026 · PMID 42349083 · candidate dictionary pubmed

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65 to 69 Years (CAREMM-2110 Study).

Jung Yeon Lee, Seungpil Jung, Sung-Soo Park et al. · Value Health · Sep 1, 2026 · PMID 42331283 · candidate dictionary pubmed

The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN).

Heinz Ludwig, Evangelos Terpos, Francesca Gay et al. · Am J Hematol · Sep 1, 2026 · PMID 42315477 · candidate dictionary pubmed

Calpain-2 inhibition alleviates hypercalcemia-driven multiple myeloma progression.

Zeyuan Wang, Chaoying Yang, Yanpeng Wang et al. · Biochem Pharmacol · Sep 1, 2026 · PMID 42315074 · candidate dictionary pubmed

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

Thomas E Kraft, Estelle Marrer-Berger, Sara Belli et al. · Clin Pharmacol Ther · Sep 1, 2026 · PMID 42310437 · candidate dictionary pubmed

Cardiovascular Toxicity of Monoclonal Antibodies Approved for Multiple Myeloma: Evidence Based on FAERS Database.

Ting Liang, Junfeng Li, Cong Xu · Ther Innov Regul Sci · Sep 1, 2026 · PMID 42289016 · candidate dictionary pubmed

Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis.

Krina Patel, Ken Hasegawa, Jie Ting et al. · Expert Rev Hematol · Sep 1, 2026 · PMID 42269717 · candidate dictionary pubmed

Understanding and addressing resistance to IMiDs immunomodulatory compounds in multiple myeloma.

Maria-Cynthia Fuentes-Lacouture, Devi Nandana, Karthik Ramasamy et al. · FEBS J · Sep 1, 2026 · PMID 42165697 · candidate dictionary pubmed

A single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states.

Mor Zada, Anna Kurilovich, Noam Shapira et al. · Nat Genet · Sep 1, 2026 · PMID 42680839 · candidate dictionary pubmed

A Multivariable Prediction Model for Early Mortality in Multiple Myeloma Patients With Renal Impairment.

Menghan Liu, Yuan Jian, Huixing Zhou et al. · Cancer Med · Sep 1, 2026 · PMID 42717545 · candidate dictionary pubmed

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg et al. · Br J Haematol · Sep 1, 2026 · PMID 42581608 · candidate dictionary pubmed

High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

Y Lisa Hwa, Dragan Jevremovic, Karen Pak et al. · Br J Haematol · Sep 1, 2026 · PMID 42543782 · candidate dictionary pubmed

Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

Damian M Mikulski, Curtis Marcoux, Mark R Tanner et al. · Br J Haematol · Sep 1, 2026 · PMID 42494235 · candidate dictionary pubmed

Prognostic significance of dynamic minimal residual disease trajectories in newly diagnosed multiple myeloma.

Jiapei Yu, Qi Chen, Min Shi et al. · Br J Haematol · Sep 1, 2026 · PMID 42481078 · candidate dictionary pubmed

The development of novel chimeric antigen receptor gamma-delta T cells against multiple myeloma and single-cell RNA sequencing analysis.

Yang Hong, Cuiling Zhang, Jue Wang et al. · Br J Haematol · Sep 1, 2026 · PMID 42438316 · candidate dictionary pubmed

A Comparative Analysis of Multiple Myeloma Disease Burden in China and Globally From 1990 to 2023 and Future Trend Projections.

Fuhong Zhu, Huiting Wang · Cancer Med · Sep 1, 2026 · PMID 42740547 · candidate dictionary pubmed

Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

Ajai Chari, Peter M Voorhees, Raymond Thertulien · Clin Adv Hematol Oncol · Sep 1, 2026 · PMID 42748346 · candidate dictionary pubmed

Prognostic Significance of Peripheral Blood Neutrophil-To-Lymphocyte Ratio (NLR), Monocyte-To-Lymphocyte Ratio (MLR), and Platelet-To-Lymphocyte Ratio (PLR) in Patients With Multiple Myeloma: A Retrospective Cohort Study.

Lihong Zhang, Bing Ma, Jingyu Zhang · J Clin Lab Anal · Sep 1, 2026 · PMID 42608992 · candidate dictionary pubmed